Pune, Maharashtra -- (SBWIRE) -- 04/17/2017 -- Global orphan diseases market was estimated to be around US$ 121.6 billion in 2015 and is expected to reach US$ 576.9 billion by 2022 by growing at a CAGR of 24.9%.

Market Highlight

The global orphan diseases market has been evaluated to be rapidly growing market and it is expected that it will grow at tremendous rate in the future. Orphan diseases are mostly genetic and exists lifelong with the patient; they are also known as rare diseases and affects small number of patient population. About 80% of orphan disease disorders are genetic. Rising consumer awareness and continuous development of treatment for orphan diseases are driving the growth of this market. Major drugs manufacturers are looking positively towards the orphan disease drug segment and investing huge amount in R&D of the same. Many countries are forming norms and acts for the treatment and cure of orphan diseases.

There are several factors which are prohibiting the growth of this market which includes extremely high cost of orphan disease treatment and drugs and absence of correct diagnosis, appropriate treatment, healthcare facilities, and information about the orphan disease disorders etc.

Request for Sample Report@ https://www.marketresearchfuture.com/sample_request/2547

Regional Analysis:

Depending on the geographic region, orphan diseases market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Considering the global scenario of the market, North America comprise the largest market share of the global orphan diseases market. Moreover the European market is also growing continuously and slowly catching up with the growth and volume of the American market and is expected to maintain this in the future as well. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the future. Rest of the World is likely to have a limited but steady growth with respect to this market.

Key Player
-Bristol-Myers Squibb Company (US)
-Novartis AG (Switzerland)
-CELGENE CORPORATION (US)
-F. Hoffmann-La Roche Ltd (Switzerland)
-Pfizer Inc. (US)
-Alexion (US)
-Sanofi (France)
-Vertex Pharmaceuticals Incorporated (US)
-GlaxoSmithKline plc. (UK)
-Merck & Co., Inc (US)
-AbbVie Inc. (US)

Segmentation

By Type - Genetic Disorders, Blood Disorders, Cancer, Growth Disorder, Cardiovascular Diseases, Neurological Disorders, Eye Disorders and Others

By Type - Treatment Gene Therapy, Cell Therapy, Drug Therapy and Others

By End User - Hospital and Clinics, Research Laboratory and Others

By Region: North America, Asia-Pacific, Europe and Row

Browse Full OD Market @ https://www.marketresearchfuture.com/reports/orphan-diseases-market-2547

Taste the market data and market information presented in more than 78 market data tables and figures spread in 85 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on "Orphan Diseases Market Research Report –Global Forecast to 2022."

Intended Audience
-Hospitals and clinics
-Orphan diseases drug manufacturers and suppliers
-Government and independent regulatory authorities
-Research and development (R&D) companies
-Market research and consulting service providers
-Medical research laboratories
-Potential investors
-
Table of Content
1 Report Prologue
2 Market Introduction
3 Research Methodology
3.1 Research Process
3.2 Primary Research
4 Market Dynamics
4.1 Drivers
4.2 Restraints
5 Market Factor Analysis
5.1 Value/Supply Chain Analysis
5.2 Porter's 5 Forces Analysis
5.3 Pricing Analysis
6 Global Orphan diseases Market Market, By Disease Type (USD Million)
6.1 Autoimmune Disorders
6.2 Genetic Disorders
6.3 Blood Disorders
6.4 Cancer
7 Chronic Disease Management Market, By Treatment Type (USD Million)
7.1 Gene Therapy
7.2 Drug Therapy
7.3 Drug Therapy
8 Global Chronic Disease Management Market, By End User (USD Million)
8.1 Hospitals and Clinics
8.2 Research Laboratories
9 Global Orphan Disease Market, By Region (USD Million)
Continued……

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.